{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T19:54:15Z","timestamp":1792698855649,"version":"4.5.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/100008968","name":"National Research Council Sri Lanka","doi-asserted-by":"publisher","award":["11-059"],"award-info":[{"award-number":["11-059"]}],"id":[{"id":"10.13039\/100008968","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12882-017-0440-x","type":"journal-article","created":{"date-parts":[[2017,1,19]],"date-time":"2017-01-19T05:44:42Z","timestamp":1484804682000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["Potential diagnostic biomarkers for chronic kidney disease of unknown etiology (CKDu) in Sri Lanka: a pilot study"],"prefix":"10.1186","volume":"18","author":[{"given":"Saravanabavan","family":"Sayanthooran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhammika N.","family":"Magana-Arachchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lishanthe","family":"Gunerathne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tilak","family":"Abeysekera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,1,19]]},"reference":[{"key":"440_CR1","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.cca.2014.08.039","volume":"438","author":"ME Wasung","year":"2015","unstructured":"Wasung ME, Chawla LS, Madero M. Biomarkers of renal function, which and when? Clin Chim Acta. 2015;438:350\u20137.","journal-title":"Clin Chim Acta"},{"issue":"8","key":"440_CR2","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/ki.2011.198","volume":"80","author":"RG Fassett","year":"2011","unstructured":"Fassett RG, Venuthurupalli SK, Gobe GC, Coombes JS, Cooper MA, Hoy WE. Biomarkers in chronic kidney disease: a review. Kidney Int. 2011;80(8):806\u201321.","journal-title":"Kidney Int"},{"issue":"4","key":"440_CR3","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.trsl.2012.01.020","volume":"159","author":"W Ju","year":"2012","unstructured":"Ju W, Smith S, Kretzler M. Genomic biomarkers for chronic kidney disease. Transl Res. 2012;159(4):290\u2013302.","journal-title":"Transl. Res."},{"issue":"5","key":"440_CR4","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s10653-007-9129-6","volume":"30","author":"JM Bandara","year":"2008","unstructured":"Bandara JM, Senevirathna DM, Dasanayake DM, Herath V, Bandara JM, Abeysekara T, Rajapaksha KH. Chronic renal failure among farm families in cascade irrigation systems in Sri Lanka associated with elevated dietary cadmium levels in rice and freshwater fish (Tilapia). Environ Geochem Health. 2008;30(5):465\u201378.","journal-title":"Environ Geochem Health"},{"key":"440_CR5","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1471-2369-12-32","volume":"12","author":"KP Wanigasuriya","year":"2011","unstructured":"Wanigasuriya KP, Peiris-John RJ, Wickremasinghe R. Chronic kidney disease of unknown aetiology in Sri Lanka: is cadmium a likely cause? BMC Nephrol. 2011;12:32.","journal-title":"BMC Nephrol"},{"issue":"3","key":"440_CR6","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s10653-010-9339-1","volume":"33","author":"R Chandrajith","year":"2011","unstructured":"Chandrajith R, Nanayakkara S, Itai K, Aturaliya TN, Dissanayake CB, Abeysekera T, Harada K, Watanabe T, Koizumi A. Chronic kidney diseases of uncertain etiology (CKDue) in Sri Lanka: geographic distribution and environmental implications. Environ Geochem Health. 2011;33(3):267\u201378.","journal-title":"Environ Geochem Health"},{"key":"440_CR7","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/1471-2369-15-124","volume":"15","author":"C Jayasumana","year":"2014","unstructured":"Jayasumana C, Gajanayake R, Siribaddana S. Importance of Arsenic and pesticides in epidemic chronic kidney disease in Sri Lanka. BMC Nephrol. 2014;15:124.","journal-title":"BMC Nephrol"},{"key":"440_CR8","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/1471-2369-15-125","volume":"15","author":"JH Redmon","year":"2014","unstructured":"Redmon JH, Elledge MF, Womack DS, Wickremashinghe R, Wanigasuriya KP, Peiris-John RJ, Lunyera J, Smith K, Raymer JH, Levine KE. Additional perspectives on chronic kidney disease of unknown aetiology (CKDu) in Sri Lanka--lessons learned from the WHO CKDu population prevalence study. BMC Nephrol. 2014;15:125.","journal-title":"BMC Nephrol"},{"key":"440_CR9","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/1471-2369-15-103","volume":"15","author":"EA Siriwardhana","year":"2014","unstructured":"Siriwardhana EA, Perera PA, Sivakanesan R, Abeysekara T, Nugegoda DB, Weerakoon KG. Is the staple diet eaten in Medawachchiya, Sri Lanka, a predisposing factor in the development of chronic kidney disease of unknown etiology? - A comparison based on urinary beta2-microglobulin measurements. BMC Nephrol. 2014;15:103.","journal-title":"BMC Nephrol"},{"issue":"3","key":"440_CR10","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s12199-011-0237-7","volume":"17","author":"L Senevirathna","year":"2012","unstructured":"Senevirathna L, Abeysekera T, Nanayakkara S, Chandrajith R, Ratnatunga N, Harada KH, Hitomi T, Komiya T, Muso E, Koizumi A. Risk factors associated with disease progression and mortality in chronic kidney disease of uncertain etiology: a cohort study in Medawachchiya, Sri Lanka. Environ Health Prev Med. 2012;17(3):191\u20138.","journal-title":"Environ Health Prev Med"},{"issue":"11","key":"440_CR11","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1038\/ki.2011.258","volume":"80","author":"NT Athuraliya","year":"2011","unstructured":"Athuraliya NT, Abeysekera TD, Amerasinghe PH, Kumarasiri R, Bandara P, Karunaratne U, Milton AH, Jones AL. Uncertain etiologies of proteinuric-chronic kidney disease in rural Sri Lanka. Kidney Int. 2011;80(11):1212\u201321.","journal-title":"Kidney Int"},{"key":"440_CR12","doi-asserted-by":"crossref","unstructured":"Kumar M, Sarin SK: Biomarkers of Disease in Medicine. Current Trends Sci. 2009:403\u2013417. http:\/\/www.mta.ca\/pshl\/docs\/BiomarkersDiseaseMedicine.pdf . Accessed 13 Jan 2017.","DOI":"10.1016\/j.cld.2009.05.002"},{"key":"440_CR13","unstructured":"Biomarker Discovery - The Challenges and Rewards Ahead [ http:\/\/www.kellyservices.com\/US\/Careers\/Kelly-Scientific-Resources\/Bob-Chen-Essay---Future-Scientists\/ ]. Accessed 13 Jan 2017."},{"issue":"9","key":"440_CR14","doi-asserted-by":"crossref","first-page":"4023","DOI":"10.1172\/JCI45361","volume":"123","author":"BD Humphreys","year":"2013","unstructured":"Humphreys BD, Xu F, Sabbisetti V, Grgic I, Naini SM, Wang N, Chen G, Xiao S, Patel D, Henderson JM, et al. Chronic epithelial kidney injury molecule-1 expression causes murine kidney fibrosis. J Clin Invest. 2013;123(9):4023\u201335.","journal-title":"J Clin Invest"},{"key":"440_CR15","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1186\/1471-2407-10-503","volume":"10","author":"S Waalkes","year":"2010","unstructured":"Waalkes S, Atschekzei F, Kramer MW, Hennenlotter J, Vetter G, Becker JU, Stenzl A, Merseburger AS, Schrader AJ, Kuczyk MA, et al. Fibronectin 1 mRNA expression correlates with advanced disease in renal cancer. BMC Cancer. 2010;10:503.","journal-title":"BMC Cancer"},{"key":"440_CR16","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.2337\/diabetes.51.8.2629","volume":"51","author":"AH Heald","year":"2002","unstructured":"Heald AH, Siddals KW, Fraser W, Taylor W, Kaushal K, Morris J, Young RJ, White A, Gibson JM. Low circulating levels of insulin-like growth factor binding protein-1 (IGFBP-1) are closely associated with the presence of macrovascular disease and hypertension in type 2 diabetes. Diabetes. 2002;51:2629\u201335.","journal-title":"Diabetes"},{"issue":"6","key":"440_CR17","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1210\/er.2001-0033","volume":"23","author":"SM Firth","year":"2002","unstructured":"Firth SM, Baxter RC. Cellular actions of the insulin-like growth factor binding proteins. Endocr Rev. 2002;23(6):824\u201354.","journal-title":"Endocr Rev"},{"key":"440_CR18","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1046\/j.1523-1755.2002.00198.x","volume":"61","author":"H Yu","year":"2002","unstructured":"Yu H, Song Q, Freedman BI, Chao J, Chao L, Rich SS, Bowden DW. Association of the tissue kallikrein gene promoter with ESRD and hypertension. Kidney Int. 2002;61:1030\u20139.","journal-title":"Kidney Int"},{"issue":"1","key":"440_CR19","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1186\/1471-2369-14-180","volume":"14","author":"N Jayatilake","year":"2013","unstructured":"Jayatilake N, Mendis S, Maheepala P, Mehta FR. Chronic kidney disease of uncertain aetiology: prevalence and causative factors in a developing country. BMC Nephrol. 2013;14(1):180.","journal-title":"BMC Nephrol"},{"issue":"4","key":"440_CR20","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S0735-1097(02)02866-8","volume":"41","author":"S Koide","year":"2003","unstructured":"Koide S, Kugiyama K, Sugiyama S, Nakamura S, Fukushima H, Honda O, Yoshimura M, Ogawa H. Association of polymorphism in glutamate-cysteine ligase catalytic subunit gene with coronary vasomotor dysfunction and myocardial infarction. J Am Coll Cardiol. 2003;41(4):539\u201345.","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"440_CR21","doi-asserted-by":"crossref","first-page":"608","DOI":"10.3390\/toxins6020608","volume":"6","author":"FT Guilford","year":"2014","unstructured":"Guilford FT, Hope J. Deficient glutathione in the pathophysiology of mycotoxin-related illness. Toxins. 2014;6(2):608\u201323.","journal-title":"Toxins"},{"issue":"5","key":"440_CR22","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/jbt.21556","volume":"28","author":"H Budak","year":"2014","unstructured":"Budak H, Ceylan H, Kocpinar EF, Gonul N, Erdogan O. Expression of glucose-6-phosphate dehydrogenase and 6-phosphogluconate dehydrogenase in oxidative stress induced by long-term iron toxicity in rat liver. J Biochem Mol Toxicol. 2014;28(5):217\u201323.","journal-title":"J Biochem Mol Toxicol"},{"issue":"1","key":"440_CR23","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/sj.tpj.6500285","volume":"5","author":"M Ingelman-Sundberg","year":"2005","unstructured":"Ingelman-Sundberg M. Genetic polymorphisms of cytochrome P450 2D6 (CYP2D6): clinical consequences, evolutionary aspects and functional diversity. Pharmacogenomics J. 2005;5(1):6\u201313.","journal-title":"Pharmacogenomics J."},{"issue":"19","key":"440_CR24","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.2174\/0929867033456855","volume":"10","author":"DF Lewis","year":"2003","unstructured":"Lewis DF. Human cytochromes P450 associated with the phase 1 metabolism of drugs and other xenobiotics: a compilation of substrates and inhibitors of the CYP1, CYP2 and CYP3 families. Curr Med Chem. 2003;10(19):1955\u201372.","journal-title":"Curr Med Chem"},{"issue":"3\u20134","key":"440_CR25","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/(SICI)1099-0461(1999)13:3\/4<223::AID-JBT14>3.0.CO;2-Z","volume":"13","author":"JL Raucy","year":"1999","unstructured":"Raucy JL, Ingelman-Sundberg M, Carpenter S, Rannug A, Rane A, Franklin M, Romkes M. Drug metabolizing enzymes in lymphocytes. J Biochem Mol Toxicol. 1999;13(3\u20134):223\u20136.","journal-title":"J Biochem Mol Toxicol"},{"issue":"12 Pt 2","key":"440_CR26","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1093\/clinchem\/41.12.1829","volume":"41","author":"CH Sewall","year":"1995","unstructured":"Sewall CH, Bell DA, Clark GC, Tritscher AM, Tully DB, Vanden Heuvel J, Lucier GW. Induced gene transcription: implications for biomarkers. Clin Chem. 1995;41(12 Pt 2):1829\u201334.","journal-title":"Clin Chem"},{"issue":"1\u20132","key":"440_CR27","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1006\/eesa.1998.1643","volume":"40","author":"CH Walker","year":"1998","unstructured":"Walker CH. The use of biomarkers to measure the interactive effects of chemicals. Ecotoxicol Environ Saf. 1998;40(1\u20132):65\u201370.","journal-title":"Ecotoxicol Environ Saf"},{"issue":"6","key":"440_CR28","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1053\/j.ajkd.2009.04.001","volume":"53","author":"KU Eckardt","year":"2009","unstructured":"Eckardt KU, Berns JS, Rocco MV, Kasiske BL. Definition and classification of CKD: the debate should be about patient prognosis--a position statement from KDOQI and KDIGO. Am J Kidney Dis. 2009;53(6):915\u201320.","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"440_CR29","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1681\/ASN.2004121100","volume":"16","author":"TH Jafar","year":"2005","unstructured":"Jafar TH, Schmid CH, Levey AS. Serum creatinine as marker of kidney function in South Asians: a study of reduced GFR in adults in Pakistan. J Am Soc Nephrol. 2005;16(5):1413\u20139.","journal-title":"J Am Soc Nephrol"},{"key":"440_CR30","unstructured":"Levey A, Greene T, Kusek J, Beck G: A simplified equation to predict glomerular filtration rate from serum creatinine [Abstract]. J Am Soc Nephrol. 2000;11:155A."},{"issue":"3","key":"440_CR31","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1006\/bbrc.2000.3740","volume":"277","author":"S Imaoka","year":"2000","unstructured":"Imaoka S, Yoneda Y, Sugimoto T, Hiroi T, Yamamoto K, Nakatani T, Funae Y. CYP4B1 is a possible risk factor for bladder cancer in humans. Biochem Biophys Res Commun. 2000;277(3):776\u201380.","journal-title":"Biochem Biophys Res Commun"},{"issue":"8","key":"440_CR32","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1097\/01.ASN.0000078803.53165.C9","volume":"14","author":"K Koop","year":"2003","unstructured":"Koop K, Eikmans M, Baelde HJ, Kawachi H, De Heer E, Paul LC, Bruijn JA. Expression of podocyte-associated molecules in acquired human kidney diseases. J Am Soc Nephrol. 2003;14(8):2063\u201371.","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"440_CR33","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1677\/JOE-10-0128","volume":"207","author":"NH Nabilsi","year":"2010","unstructured":"Nabilsi NH, Broaddus RR, McCampbell AS, Lu KH, Lynch HT, Chen LM, Loose DS. Sex hormone regulation of survivin gene expression. J Endocrinol. 2010;207(2):237\u201343.","journal-title":"J Endocrinol"},{"issue":"5","key":"440_CR34","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1248\/yakushi.122.339","volume":"122","author":"M Nishimura","year":"2002","unstructured":"Nishimura M, Yoshitsugu H, Naito S, Hiraoka I. Evaluation of gene induction of drug-metabolizing enzymes and transporters in primary culture of human hepatocytes using high-sensitivity real-time reverse transcription PCR. J Pharm Soc Jpn. 2002;122(5):339\u201361.","journal-title":"J. Pharm. Soc. Jpn."},{"issue":"4","key":"440_CR35","first-page":"901","volume":"7","author":"H Takayasu","year":"2001","unstructured":"Takayasu H, Horie H, Hiyama E, Matsunaga T, Hayashi Y, Watanabe Y, Suita S, Kaneko M, Sasaki F, Hashizume K, et al. Frequent deletions and mutations of the beta-catenin gene are associated with overexpression of cyclin D1 and fibronectin and poorly differentiated histology in childhood hepatoblastoma. Clin Cancer Res. 2001;7(4):901\u20138.","journal-title":"Clin Cancer Res"},{"issue":"4","key":"440_CR36","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(\u2212Delta Delta C(T)) Method. Methods. 2001;25(4):402\u20138.","journal-title":"Methods"},{"issue":"Suppl 4","key":"440_CR37","doi-asserted-by":"crossref","first-page":"iv105","DOI":"10.1093\/ndt\/gfv210","volume":"30","author":"HJ Lambers Heerspink","year":"2015","unstructured":"Lambers Heerspink HJ, Oberbauer R, Perco P, Heinzel A, Heinze G, Mayer G, Mayer B. Drugs meeting the molecular basis of diabetic kidney disease: bridging from molecular mechanism to personalized medicine. Nephrol Dial Transplant. 2015;30 Suppl 4:iv105\u201312.","journal-title":"Nephrol Dial Transplant"},{"issue":"Suppl 4","key":"440_CR38","doi-asserted-by":"crossref","first-page":"iv1","DOI":"10.1093\/ndt\/gfv120","volume":"30","author":"JF Mann","year":"2015","unstructured":"Mann JF, Rossing P, Wiecek A, Rosivall L, Mark P, Mayer G. Diagnosis and treatment of early renal disease in patients with type 2 diabetes mellitus: what are the clinical needs? Nephrol Dial Transplant. 2015;30 Suppl 4:iv1\u20135.","journal-title":"Nephrol Dial Transplant"},{"key":"440_CR39","unstructured":"Fink HA, Ishani A, Taylor BC, Greer NL, MacDonald R, Rossini D, Sadiq S, Lankireddy S, Kane RL, Wilt TJ. Chronic Kidney Disease Stages 1\u20133: Screening, Monitoring, and Treatment. Comparative Effectiveness Review No. 37. (Prepared by the Minnesota Evidence-based Practice Center under Contract No. HHSA 290-2007-10064-I.) AHRQ Publication No. 11(12)-EHC075-EF. Rockville, MD: Agency for Healthcare Research and Quality. 2012. www.effectivehealthcare.ahrq.gov\/reports\/final.cfm ."},{"issue":"12","key":"440_CR40","first-page":"2219","volume":"6","author":"GT Ooi","year":"1992","unstructured":"Ooi GT, Tseng LYH, Tran MQ, Rechler MM. Insulin rapidly decreases insulin-like growth factor-binding protein-1 gene transcription in streptozotocin-diabetic rats. Mol Endocrinol. 1992;6(12):2219\u201328.","journal-title":"Mol Endocrinol"},{"issue":"1","key":"440_CR41","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1868-7083-6-10","volume":"6","author":"T Gu","year":"2014","unstructured":"Gu T, Falhammar H, Gu HF, Brismar K. Epigenetic analyses of the insulin-like growth factor binding protein 1 gene in type 1 diabetes and diabetic nephropathy. Clin Epigenetics. 2014;6(1):10.","journal-title":"Clin. Epigenetics"},{"issue":"7","key":"440_CR42","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1007\/s00125-008-1016-x","volume":"51","author":"MS Lewitt","year":"2008","unstructured":"Lewitt MS, Hilding A, Ostenson CG, Efendic S, Brismar K, Hall K. Insulin-like growth factor-binding protein-1 in the prediction and development of type 2 diabetes in middle-aged Swedish men. Diabetologia. 2008;51(7):1135\u201345.","journal-title":"Diabetologia"},{"issue":"3","key":"440_CR43","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.diabet.2008.11.003","volume":"35","author":"U Petersson","year":"2009","unstructured":"Petersson U, Ostgren CJ, Brudin L, Brismar K, Nilsson PM. Low levels of insulin-like growth-factor-binding protein-1 (IGFBP-1) are prospectively associated with the incidence of type 2 diabetes and impaired glucose tolerance (IGT): the Soderakra Cardiovascular Risk Factor Study. Diabetes Metab. 2009;35(3):198\u2013205.","journal-title":"Diabetes Metab."},{"issue":"1","key":"440_CR44","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1868-7083-5-21","volume":"5","author":"T Gu","year":"2013","unstructured":"Gu T, Gu HF, Hilding A, Sjoholm LK, Ostenson CG, Ekstrom TJ, Brismar K. Increased DNA methylation levels of the insulin-like growth factor binding protein 1 gene are associated with type 2 diabetes in Swedish men. Clin Epigenetics. 2013;5(1):21.","journal-title":"Clin. Epigenetics"},{"issue":"1","key":"440_CR45","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.metabol.2011.05.014","volume":"61","author":"K Gokulakrishnan","year":"2012","unstructured":"Gokulakrishnan K, Velmurugan K, Ganesan S, Mohan V. Circulating levels of insulin-like growth factor binding protein-1 in relation to insulin resistance, type 2 diabetes mellitus, and metabolic syndrome (Chennai Urban Rural Epidemiology Study 118). Metab Clin Exp. 2012;61(1):43\u20136.","journal-title":"Metab Clin Exp"},{"issue":"10","key":"440_CR46","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1681\/ASN.2013070758","volume":"25","author":"VS Sabbisetti","year":"2014","unstructured":"Sabbisetti VS, Waikar SS, Antoine DJ, Smiles A, Wang C, Ravisankar A, Ito K, Sharma S, Ramadesikan S, Lee M, et al. Blood kidney injury molecule-1 is a biomarker of acute and chronic kidney injury and predicts progression to ESRD in type I diabetes. J Am Soc Nephrol. 2014;25(10):2177\u201386.","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"440_CR47","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1093\/toxsci\/kfm260","volume":"101","author":"Y Zhou","year":"2008","unstructured":"Zhou Y, Vaidya VS, Brown RP, Zhang J, Rosenzweig BA, Thompson KL, Miller TJ, Bonventre JV, Goering PL. Comparison of kidney injury molecule-1 and other nephrotoxicity biomarkers in urine and kidney following acute exposure to gentamicin, mercury, and chromium. Toxicol Sci. 2008;101(1):159\u201370.","journal-title":"Toxicol Sci"},{"issue":"5","key":"440_CR48","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1155\/2013\/183246","volume":"35","author":"S Simic Ogrizovic","year":"2013","unstructured":"Simic Ogrizovic S, Bojic S, Basta-Jovanovic G, Radojevic S, Pavlovic J, Kotur Stevuljevic J, Dopsaj V, Naumovic R. Tissue kidney injury molecule-1 expression in the prediction of renal function for several years after kidney biopsy. Dis Markers. 2013;35(5):567\u201372.","journal-title":"Dis Markers"},{"issue":"4","key":"440_CR49","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.4049\/jimmunol.1402632","volume":"194","author":"S Xiao","year":"2015","unstructured":"Xiao S, Brooks CR, Sobel RA, Kuchroo VK. Tim-1 is essential for induction and maintenance of IL-10 in regulatory B cells and their regulation of tissue inflammation. J Immunol. 2015;194(4):1602\u20138.","journal-title":"J. Immunol."},{"issue":"4","key":"440_CR50","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.immuni.2014.03.004","volume":"40","author":"S Angiari","year":"2014","unstructured":"Angiari S, Donnarumma T, Rossi B, Dusi S, Pietronigro E, Zenaro E, Della Bianca V, Toffali L, Piacentino G, Budui S, et al. TIM-1 glycoprotein binds the adhesion receptor P-selectin and mediates T cell trafficking during inflammation and autoimmunity. Immunity. 2014;40(4):542\u201353.","journal-title":"Immunity"},{"key":"440_CR51","doi-asserted-by":"crossref","first-page":"7546265","DOI":"10.1155\/2016\/7546265","volume":"2016","author":"S Sayanthooran","year":"2016","unstructured":"Sayanthooran S, Magana-Arachchi DN, Gunerathne L, Abeysekera TDJ, Sooriyapathirana SS. Upregulation of oxidative stress related genes in a chronic kidney disease attributed to specific geographical locations of Sri Lanka. Biomed Res Int. 2016;2016:7546265.","journal-title":"Biomed Res Int"},{"issue":"9","key":"440_CR52","doi-asserted-by":"crossref","first-page":"702","DOI":"10.2459\/JCM.0b013e32835dbcc8","volume":"15","author":"N Stoynev","year":"2014","unstructured":"Stoynev N, Dimova I, Rukova B, Hadjidekova S, Nikolova D, Toncheva D, Tankova T. Gene expression in peripheral blood of patients with hypertension and patients with type 2 diabetes. J Cardiovasc Med (Hagerstown). 2014;15(9):702\u20139.","journal-title":"J. Cardiovasc. Med. (Hagerstown)"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-017-0440-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,22]],"date-time":"2022-07-22T01:48:24Z","timestamp":1658454504000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-017-0440-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,19]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["440"],"URL":"https:\/\/doi.org\/10.1186\/s12882-017-0440-x","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,19]]},"article-number":"31"}}